Emergent Bio

EBS NYSE
43.58
-0.68
-1.54%
After Hours: 43.58 0 0.00% 16:51 05/22 EDT
Open
44.05
Prev Close
44.26
High
44.12
Low
42.81
Volume
325.91K
Avg Vol (3M)
594.49K
52 Week High
73.89
52 Week Low
42.29
% Turnover
0.63%
Market Cap
2.24B
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Emergent Bio EBS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
MORE >

Recently

Name
Price
%Change